Atossa Therapeutics, Inc.
Atossa Therapeutics, Inc. scores highest on Torque (60) and lowest on Nitro (27). Its PosiPenta is 37.28 out of 100, weaker than most similar companies.
On the Penta Grid this week, Atossa Therapeutics, Inc. is Grid #624 of 837 in the Healthcare sector in United States, and Grid #3,125 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Atossa Therapeutics, Inc. | 37.28 | 38 | 28 | 27 | 60 | 34 |
| DocGo Inc. | 39.62 | 49 | 57 | 19 | 33 | 40 |
| MIRA Pharmaceuticals, Inc. | 40.02 | 20 | 55 | 27 | 51 | 46 |
| ABVC BioPharma, Inc. | 38.47 | 25 | 40 | 31 | 39 | 57 |
| Milestone Scientific Inc. | 39.72 | 8 | 52 | 57 | 34 | 48 |
| CEL-SCI Corporation | 26.87 | 22 | 20 | 27 | 18 | 47 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.65 |
| P/B ratio | 1.08 |
EEarnings
| Trailing EPS | ₹-421.48 |
| Forward EPS | ₹-312.56 |
NNitro
| Price | 275.62 |
| 52-week high | 1463.35 |
| 52-week low | 161.02 |
| Fall from 52-week high | 81.2% |
TTorque
| Return on equity (ROE) | -89.23% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 1.27 |
| Market cap | ₹275 Cr |
| Insider holding | 1.85% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Atossa Therapeutics, Inc.'s PosiPenta score?
Atossa Therapeutics, Inc.'s PosiPenta is 37.28 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Atossa Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Atossa Therapeutics, Inc. is Grid #624 of 837 in the Healthcare sector in United States, and Grid #3,125 of 4,000 in United States.
Which PosiPenta pillar is strongest for Atossa Therapeutics, Inc.?
Torque (durability), with a score of 60 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Atossa Therapeutics, Inc.?
Nitro (momentum), with a score of 27 out of 100: weaker than most similar companies.
Has Atossa Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.71 points, from 33.57 to 37.28.
PositoAI is for research and education only and is not investment advice.